159 related articles for article (PubMed ID: 20639044)
21. Comparison of percutaneous endopyelotomy with open pyeloplasty for pediatric ureteropelvic junction obstruction.
Schenkman EM; Tarry WF
J Urol; 1998 Mar; 159(3):1013-5. PubMed ID: 9474220
[TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of health related quality of life for pediatric patients with ureteropelvic junction obstruction.
Parekh AD; Thomas JC; Trusler L; Ankerst DP; Deshpande JK; Adams MC; Pope JC; Brock JW
J Urol; 2008 Nov; 180(5):2171-5; discussion 2175-6. PubMed ID: 18804796
[TBL] [Abstract][Full Text] [Related]
23. Retroperitoneoscopic pyeloplasty: using reconstructive methods based on intraoperative findings.
Kawa G; Tatsumi M; Hiura Y; Muguruma K; Kinoshita H; Matsuda T
Int J Urol; 2006 Sep; 13(9):1171-4. PubMed ID: 16984547
[TBL] [Abstract][Full Text] [Related]
24. Collagen-to-smooth muscle ratio helps prediction of prognosis after pyeloplasty.
Kim WJ; Yun SJ; Lee TS; Kim CW; Lee HM; Choi H
J Urol; 2000 Apr; 163(4):1271-5. PubMed ID: 10737527
[TBL] [Abstract][Full Text] [Related]
25. Congenital ureteropelvic junction obstruction: physiopathology, decoupling of tout court pelvic dilatation-obstruction semantic connection, biomarkers to predict renal damage evolution.
Alberti C
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):213-9. PubMed ID: 22428472
[TBL] [Abstract][Full Text] [Related]
26. Hypertension is an indication for surgery in children with ureteropelvic junction obstruction.
de Waard D; Dik P; Lilien MR; Kok ET; de Jong TP
J Urol; 2008 May; 179(5):1976-8; discussion 1978-9. PubMed ID: 18355868
[TBL] [Abstract][Full Text] [Related]
27. Ureteropelvic junction obstruction in children with renal ectopy.
Kramer SA; Kelalis PP
J Urol (Paris); 1984; 90(5):331-6. PubMed ID: 6501910
[TBL] [Abstract][Full Text] [Related]
28. Retrograde treatment of ureteropelvic junction obstruction using the ureteral cutting balloon catheter.
Faerber GJ; Richardson TD; Farah N; Ohl DA
J Urol; 1997 Feb; 157(2):454-8. PubMed ID: 8996330
[TBL] [Abstract][Full Text] [Related]
29. Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor.
Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE
BJU Int; 2007 Apr; 99(4):899-903. PubMed ID: 17378848
[TBL] [Abstract][Full Text] [Related]
30. Fibroepithelial polyps causing ureteropelvic junction obstruction in children.
Adey GS; Vargas SO; Retik AB; Borer JG; Mandell J; Hendren WH; Lebowitz RL; Bauer SB
J Urol; 2003 May; 169(5):1834-6. PubMed ID: 12686857
[TBL] [Abstract][Full Text] [Related]
31. Dynamic renal scintigraphy in children with vesicoureteral reflux and suspected coexisting ureteropelvic junction obstruction.
Stauss J; Connolly LP; Connolly SA; Zurakowski D; Treves ST; Peters CA
J Urol; 2003 Nov; 170(5):1966-70. PubMed ID: 14532835
[TBL] [Abstract][Full Text] [Related]
32. [Improved prognosis and treatment of hydronephrosis due to ureteropelvic junction syndrome in children].
Frering V; Sabatier E; Takvorian P; Dodat H
Prog Urol; 1991 Dec; 1(6):1000-5. PubMed ID: 1844729
[TBL] [Abstract][Full Text] [Related]
33. Missed anterior crossing vessels during open retroperitoneal pyeloplasty: laparoscopic transperitoneal discovery and repair.
Rehman J; Landman J; Sundaram C; Clayman RV
J Urol; 2001 Aug; 166(2):593-6. PubMed ID: 11458074
[TBL] [Abstract][Full Text] [Related]
34. Urinary polyomavirus: novel biomarker of congenital ureteropelvic junction obstruction.
Assadi F; Mazaheri M
J Pediatr Urol; 2020 Feb; 16(1):107.e1-107.e5. PubMed ID: 31818677
[TBL] [Abstract][Full Text] [Related]
35. [Lower pole pedicle in a series of 84 pyelo-ureteral junction syndromes surgically treated in children].
Lopez C; A'ch S; Veyrac C; Morin D; Averous M
Prog Urol; 2000 Sep; 10(4):638-43. PubMed ID: 11064915
[TBL] [Abstract][Full Text] [Related]
36. Ureteropelvic junction obstruction in utero and ex utero.
Ghidini A; Sirtori M; Vergani P; Orsenigo E; Tagliabue P; Parravicini E
Obstet Gynecol; 1990 May; 75(5):805-8. PubMed ID: 2183108
[TBL] [Abstract][Full Text] [Related]
37. Surgical management of congenital ureteropelvic junction obstruction: a Pediatric Health Information System database study.
Vemulakonda VM; Cowan CA; Lendvay TS; Joyner BD; Grady RW
J Urol; 2008 Oct; 180(4 Suppl):1689-92; discussion 1692. PubMed ID: 18708209
[TBL] [Abstract][Full Text] [Related]
38. Renal glomerular response to the inhibition of prostaglandin E2 synthesis and protein loading after the relief of unilateral ureteropelvic junction obstruction.
Montini G; Sacchetto E; Murer L; Dall'Amico R; Masiero M; Passerini-Glazel G; Zacchello G
J Urol; 2000 Feb; 163(2):556-60. PubMed ID: 10647684
[TBL] [Abstract][Full Text] [Related]
39. Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction.
Yu L; Zhou L; Li Q; Li S; Luo X; Zhang C; Wu B; Brooks JD; Sun H
J Pediatr Urol; 2019 Feb; 15(1):44.e1-44.e7. PubMed ID: 30420258
[TBL] [Abstract][Full Text] [Related]
40. Ipsilateral pyeloureterostomy for managing lower pole reflux with associated ureteropelvic junction obstruction in duplex systems.
Shelfo SW; Keller MS; Weiss RM
J Urol; 1997 Apr; 157(4):1420-2. PubMed ID: 9120969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
